Avalon BioVentures is a biotech venture capital firm based in La Jolla, California, focusing on early-stage life science investments. With a 40-year track record, the firm specializes in identifying and supporting disruptive ideas in the biotech sector. Avalon BioVentures typically participates in seed-stage funding rounds, as evidenced by their investment history.

The firm leverages its Accelerator program to provide operational infrastructure and support to portfolio companies. Notable investments include Arialys Therapeutics, which has raised $58 million. Avalon BioVentures' team brings extensive experience in building agile companies and advancing breakthrough therapeutics, offering valuable insights to entrepreneurs due to their firsthand industry experience.